A phase I clinical trial of SEP-378614 in depressive disorders
Latest Information Update: 18 Jan 2024
At a glance
- Drugs SEP 378614 (Primary)
- Indications Depressive disorders
- Focus Adverse reactions
- 06 Oct 2021 New trial record
Latest Information Update: 18 Jan 2024